<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Elevance Health (ELV): 3 Reasons We Love This Stock — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Elevance Health (ELV): 3 Reasons We Love This Stock</h2>
    <div class="badge">2025-09-09T04:01:17+00:00</div>
    <ul>
      <li>The stock dropped 24.6% and now trades at $308.66.</li>
<li>After the recent drawdown, the stock trades at 8.4× forward P/E (or $308.66 per share).</li>
<li>Elevance Health’s five-year average ROIC was 27.1%, placing it among the best healthcare companies.</li>
<li>With $188.2 billion in revenue over the past 12 months, Elevance Health is one of the most scaled enterprises in healthcare.</li>
<li>Over the next 12 months, sell-side analysts expect Elevance Health’s revenue to rise by 8.5%, an improvement versus its 10.7% annualized growth for the past five years.</li>
<li>1.</li>
<li>2.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Elevance%20Health%20%28ELV%29%3A%203%20Reasons%20We%20Love%20This%20Stock%0A%E2%80%A2%20The%20stock%20dropped%2024.6%25%20and%20now%20trades%20at%20%24308.66.%0A%E2%80%A2%20After%20the%20recent%20drawdown%2C%20the%20stock%20trades%20at%208.4%C3%97%20forward%20P%2FE%20%28or%20%24308.66%20per%20share%29.%0A%E2%80%A2%20Elevance%20Health%E2%80%99s%20five-year%20average%20ROIC%20was%2027.1%25%2C%20placing%20it%20among%20the%20best%20healthcare%20companies.%0A%E2%80%A2%20With%20%24188.2%20billion%20in%20revenue%20over%20the%20past%2012%20months%2C%20Elevance%20Health%20is%20one%20of%20the%20most%20scaled%20enterprises%20in%20healthcare.%0A%E2%80%A2%20Over%20the%20next%2012%20months%2C%20sell-side%20analysts%20expect%20Elevance%20Health%E2%80%99s%20revenue%20to%20rise%20by%208.5%25%2C%20an%20improvement%20versus%20its%2010.7%25%20annualized%20growth%20for%20the%20past%20five%20years.%0A%E2%80%A2%201.%0A%E2%80%A2%202.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Felevance-health-elv-3-reasons-we-love-this-stock%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/elevance-health-elv-3-reasons-040117983.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>